There is a long history of discovery and development in the field of functional urology. While current commercial research has slowed- there is still an unmet need for the development of new and selective pharmaceutical treatments for a wide range of urological conditions. These functional disorders can significantly impact quality of life and have a major economic impact.

In this session will highlight topics that include the incorporation of patient-based factors in drug design, how sensory modulation is crucial for the selective treatment of overactive bladder, a look to potential therapeutic strategies for management of LUTS and innovative approaches in diagnostics such as artificial intelligence which may help to predict and enhance patient outcomes.